Summary
In most countries, calcitonin is available in the form of injections, and less frequently as an intranasal spray. An oral route of administration should improve compliance. In a preliminary feasibility study, we have compared the acute biological action of injectable salmon calcitonin (50 IU), with the injectable calcitonin analogue ASC 710 (0.2 mg) and oral ASC 710 (20 mg) in 6 patients suffering from active Paget's disease of bone. The intensity and duration of the biological response were not significantly different in the 3 modes of therapy. In conclusion, the oral calcitonin analogue ASC 710 possesses an antiresorbing activity in Paget's disease comparable to that of an injection of salmon calcitonin which demonstrates that it can cross the intestinal barrier.
This is a preview of subscription content, log in via an institution to check access.
References
Nagant de Deuxchaisnes C (1983) Calcitonin in the treatment of Paget's disease. Triangle 22: 103–128
Nagant de Deuxchaisnes C (1990) Use of calcitonin in the treatment of postmenopausal osteoporosis. In: DeLuca HF, Mazess R (eds) Osteoporosis: Physiological Basis, Assessment, and Treatment. Elsevier Science Publishing Co. New York, pp. 247
Civitelli R, Gonelli S, Zacchei F, Bigazzi S, Vattimo A, Avioli LV, Gennari C (1988) Bone turnover in postmenopausal osteoporosis: effects of calcitonin treatment. J Clin Invest 82: 1268–1274
Nagant de Deuxchaisnes C, Devogelaer JP, Huaux JP, Dufour JP, Esselinckx W, Engelbeen JP, Stasse P, Hermans P, De Buisseret JP (1987) New modes of adrministration of salmon calcitonin in Paget's disease. Clin Orthop Rel Res 217: 56–70
Thiebaud D, Burkhardt P, Jaeger Ph, Azria M (1987) Effectiveness of salmon calcitonin as suppositories in tumor-induced hypercalcemia. Am J Med 82: 745–750
Overgaard K, Riis BJ, Christiansen C, Podenphant J, Johansen JS, (1989) Nasal calcitonin for treatment of established osteoporosis. Clin Endocrinol 30: 435–442
Trechsel U, Azria M, Bruns C, Feyen JMH, Gamse R, Cardinaux F (1993) A new orally active calcitonin analogue with a distinct pharmacological profile. J Bone Min Res 8 (suppl. 1) : S200
Bessey OA, Lowry OH, Brock MJ (1946) A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. J Biol Chem 164: 321–324
Abbiati G, Bartucci F, Longoni A, Fincato G, Galimberti S, Rigoldi M, Castiglioni C (1993) Monitoring of free and total urinary pyridinoline and deoxypyridinoline in healthy volunteers: sample relationships between 24-h and fasting early morning urine concentrations. Bone Miner 21: 9–19
Harinck HIJ, Bijvoet OLM, Blanksma HK, Dahlinghaus-Nienhuys PJ (1987) Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone. Clin Orthop Rel Res 217: 79–98
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Devogelaer, J.P., Azria, M., Attinger, M. et al. Comparison of the acute biological action of injectable salmon calcitonin and an injectable and oral calcitonin analogue. Calcif Tissue Int 55, 71–73 (1994). https://doi.org/10.1007/BF00310172
Issue Date:
DOI: https://doi.org/10.1007/BF00310172